METEX Share Price Performance
€0
0.00 (0.00%)
Sorry, there is currently no price data for this company.
METabolic EXplorer S.A. (EPA:METEX) Surges 28% Yet Its Low P/S Is No Reason For Excitement
Feb 10
METabolic EXplorer S.A. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
METEX Community Narratives
There are no narratives available yet.
Recent METEX News & Updates
METabolic EXplorer S.A. Key Details
Last Reported Earnings
Jun 30, 2023
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.97
- Gross Margin
- -3.90%
- Net Profit Margin
- -29.34%
- Debt/Equity Ratio
- 122.3%
METabolic EXplorer S.A. Competitors
Snowflake Analysis
About METEX
- Founded
- 1999
- Employees
- 450
- CEO
- WebsiteView website
METabolic EXplorer S.A., a biological chemistry company, engages in the development and industrialization of industrial fermentation processes as alternatives to petrochemical processes worldwide. The company also offers propanediol, butyric acid, butyric acid, glycolic acid, amino acid, and L-Valine. Its products are used in the formulation of cosmetics, textiles, polymer, animal nutrition, and health products or as intermediates for the synthesis of biomaterials. The company was incorporated in 1999 and is based in Saint-Beauzire, France.
Market Insight
Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading
French Market Performance
- 7 Days: -2.2%
- 3 Months: 0.3%
- 1 Year: 2.8%
- Year to Date: 5.1%
Over the last 7 days, the market has dropped 2.2%, driven by a decline of 3.0% in the Consumer Discretionary sector. In the last 12 months the market has been flat overall. Earnings are forecast to grow by 12% annually. Market details ›